Mark Cochran leads the Johns Hopkins HealthCare Solutions team, a unique initiative charged with expanding and managing partnerships with the business world, fostering collaborations among faculty and clinicians to leverage their intellectual assets, and bringing to external markets evidence-based innovations that address the wide range of population health challenges.
Dr. Cochran’s professional experience spans the spectrum of the global health care value chain including drug discovery, business development, clinical research, program management, and venture capital initiatives. He has held leadership positions in organizations such as Bayer Pharmaceuticals (in Germany and USA), Blanchette Rockefeller Neurosciences Institute, MDS Capital Corp., and NeuroVentures Capital.
An inventor of several recombinant vaccines and other biological products, and author of a number of scientific papers, Dr. Cochran also co-founded MicroGeneSys Inc., a Connecticut-based vaccine company, now called Protein Sciences.
Dr. Cochran holds a doctoral degree in Microbiology and Immunology from Queen’s University, in Kingston, Ontario; a master’s degree in microbiology from the University of Guelph, in Ontario; and a bachelor’s degree from the University of Toronto. He also was a postdoctoral Fellow at the National Institutes of Health, Bethesda, MD.